Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Lord

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Toxicology Letters|April 20, 2004
Progress in applying genomics in drug developmentPeter G Lord
Science (New York, N.Y.)|October 23, 2004
Genomics and drug toxicityPeter G Lord, Thomas Papoian
Basic & Clinical Pharmacology & Toxicology|May 17, 2006
Application of genomics in preclinical drug safety evaluationPeter G Lord, Alex Nie, Michael McMillian
Toxicology Mechanisms and Methods|December 22, 2009
The evolution of gene expression studies in drug safety assessmentPeter G Lord, Alex Nie, Michael McMillian
Environmental Health Perspectives|March 23, 2004
Toxicogenomics in risk assessment: an overview of an HESI collaborative research programWilliam Pennie, Syril D Pettit, Peter G Lord
Biochemical Pharmacology|December 12, 2003
Gene expression changes in rat liver following exposure to liver growth agents: role of Kupffer cells in xenobiotic-mediated liver growthSarah E Crunkhorn, Kathryn E Plant, Gordon G Gibson, et al.
Proteomics|November 21, 2002
Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley ratWai J Man, Ian R White, Duncan Bryant, et al.
Molecular Carcinogenesis|August 22, 2006
Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicityAlex Y Nie, Michael McMillian, J Brandon Parker, et al.
Proteomics|April 11, 2003
Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligandsIan R White, Wai J Man, Duncan Bryant, et al.
Chemical Research in Toxicology|March 27, 2007
Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expressionAngelique M Leone, L M Kao, Michael K McMillian, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Toxicology Letters|April 20, 2004
Progress in applying genomics in drug developmentPeter G Lord
Science (New York, N.Y.)|October 23, 2004
Genomics and drug toxicityPeter G Lord, Thomas Papoian
Basic & Clinical Pharmacology & Toxicology|May 17, 2006
Application of genomics in preclinical drug safety evaluationPeter G Lord, Alex Nie, Michael McMillian
Toxicology Mechanisms and Methods|December 22, 2009
The evolution of gene expression studies in drug safety assessmentPeter G Lord, Alex Nie, Michael McMillian
Environmental Health Perspectives|March 23, 2004
Toxicogenomics in risk assessment: an overview of an HESI collaborative research programWilliam Pennie, Syril D Pettit, Peter G Lord
Biochemical Pharmacology|December 12, 2003
Gene expression changes in rat liver following exposure to liver growth agents: role of Kupffer cells in xenobiotic-mediated liver growthSarah E Crunkhorn, Kathryn E Plant, Gordon G Gibson, et al.
Proteomics|November 21, 2002
Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley ratWai J Man, Ian R White, Duncan Bryant, et al.
Molecular Carcinogenesis|August 22, 2006
Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicityAlex Y Nie, Michael McMillian, J Brandon Parker, et al.
Proteomics|April 11, 2003
Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligandsIan R White, Wai J Man, Duncan Bryant, et al.
Chemical Research in Toxicology|March 27, 2007
Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expressionAngelique M Leone, L M Kao, Michael K McMillian, et al.
Pageof 2